​
Login / Signup
Roger J Liang
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Cell Proliferation
Metastatic Colorectal Cancer
Wild Type
Basal Cell Carcinoma
Top Venues
Cancer immunology research
Cancer discovery
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Gabriele Romano
,
Francesca Paradiso
,
Peng Li
,
Pooja Shukla
,
Lindsay N Barger
,
Olivia El Naggar
,
John P Miller
,
Roger J Liang
,
Timothy L Helms
,
Alexander J F Lazar
,
Jennifer A Wargo
,
Francesca Taraballi
,
James C Costello
,
Lawrence N Kwong
Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma.
Cancer immunology research
(2023)
Gabriele Romano
,
Francesca Paradiso
,
Peng Li
,
Pooja Shukla
,
Lindsay N Barger
,
Olivia El Naggar
,
John P Miller
,
Roger J Liang
,
Timothy L Helms
,
Alexander J F Lazar
,
Jennifer A Wargo
,
Francesca Taraballi
,
James C Costello
,
Lawrence N Kwong
Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma.
Cancer immunology research
(2023)
Benjamin D Stein
,
John R Ferrarone
,
Eric E Gardner
,
Jae Won Chang
,
David Wu
,
Pablo E Hollstein
,
Roger J Liang
,
Min Yuan
,
Qiuying Chen
,
John S Coukos
,
Miriam Sindelar
,
Bryan Ngo
,
Steven S Gross
,
Reuben J Shaw
,
Chen Zhang
,
John M Asara
,
Raymond E Moellering
,
Harold Varmus
,
Lewis C Cantley
LKB1-dependent regulation of TPI1 creates a divergent metabolic liability between human and mouse lung adenocarcinoma.
Cancer discovery
(2023)